This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Moroni, G Articles by Ponticelli, C Search for Related Content PubMed PubMed Citation Articles by Moroni, G Articles by Ponticelli, C Social Bookmarking                         What's this?

Pregnancy after lupus nephritis

Unita’ Operativa di Nefrologia, IRCCS Ospedale Maggiore Policlinico, Milano, croff1{at}policlinico.mi.it

C Ponticelli

IRCSS Instituto Auxologico Milano

Systemic lupus erythematosus (SLE) is an autoimmune disease that affects primarily women, commonly in their reproductive years but does not influence fertility. For these reasons, the clinician has often to face the many problems of pregnancy in patients with SLE including the influence of SLE on fetal outcome and that of pregnancy on SLE. As there is increasing evidence of an important role of sex hormones in immunity, the influence of pregnancy on SLE is probably due to the changes in sex hormone levels during pregnancy that are more important than in any other period of life.

Early reports emphasized a high fetal and maternal risk in particular in patients with lupus nephritis. However in the same period the prognosis of lupus nephritis was poor, so it was difficult to know whether pregnancy actually influenced the prognosis of the disease. More recent prospective studies indicate that pregnancy is safe for the majority of mothers if it is planned when SLE is quiescent. Instead, although fetal risk has been progressively reduced in the last 40 years, it continues to be higher than that occurring in pregnancies of healthy women. In particular the presence of antiphospholipid antibodies considerably worsen the fetal outcome.

Key Words: antiphosholipid antibodies • lupus nephritis • pregnancy

Lupus, Vol. 14, No. 1, 89-94 (2005)
DOI: 10.1191/0961203305lu2066oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. E. Elizur, R. C. Chian, C. A. Pineau, W. Y. Son, H. E. G. Holzer, J. Y. J. Huang, Y. Gidoni, D. Levin, E. Demirtas, and S. L. Tan Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents Rheumatology, October 1, 2008; 47(10): 1506 - 1509. [Abstract] [Full Text] [PDF]

				A. Doria, A. Tincani, and M. Lockshin Challenges of lupus pregnancies Rheumatology, June 1, 2008; 47(suppl_3): iii9 - iii12. [Abstract] [Full Text] [PDF]

				M. Gayed and C. Gordon Pregnancy and rheumatic diseases Rheumatology, November 1, 2007; 46(11): 1634 - 1640. [Abstract] [Full Text] [PDF]

				J Spiegel, M L Ishimori, D J Wallace, and M H Weisman The lowest surviving birth weight reported in a systemic lupus erythematosus patient: a review of the literature Lupus, January 1, 2007; 16(1): 52 - 55. [Abstract] [PDF]

				N. C. T. Kong Pregnancy of a lupus patient--a challenge to the nephrologist Nephrol. Dial. Transplant., February 1, 2006; 21(2): 268 - 272. [Full Text] [PDF]